DD
46
-2
CCL
44
4
AES
49
-5
AIV
61
10
O
37
-2
CHK
41
2
EFX
58
14
FRT
51
-4
SCHW
56
-3
FAST
48
3
HOG
26
-16
DTE
56
-2
UAL
58
2
FOXA
35
-2
XEL
55
-2
STT
48
-5
DOV
76
7
AIZ
68
-5
DO
49
-5
MSFT
55
-5
DD
46
-2
CCL
44
4
AES
49
-5
AIV
61
10
O
37
-2
CHK
41
2
EFX
58
14
FRT
51
-4
SCHW
56
-3
FAST
48
3
HOG
26
-16
DTE
56
-2
UAL
58
2
FOXA
35
-2
XEL
55
-2
STT
48
-5
DOV
76
7
AIZ
68
-5
DO
49
-5
MSFT
55
-5
Financhill
Back

NeoGenomics 10K Form

Sell
32

NEO
NeoGenomics

Last Price:
14.23
Seasonality Move:
3.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-06 10Q NEO/NeoGenomics Quarterly
2023-08-08 10Q NEO/NeoGenomics Quarterly
2023-05-09 10Q NEO/NeoGenomics Quarterly
2022-11-08 10Q NEO/NeoGenomics Quarterly
2022-08-09 10Q NEO/NeoGenomics Quarterly
2022-05-09 10Q NEO/NeoGenomics Quarterly

Receive NEO News And Ratings

See the #1 stock for the next 7 days that we like better than NEO

NEO Financial Statistics

Sales & Book Value

Annual Sales: $591.64M
Cash Flow: $10.73M
Price / Cash Flow: 0
Annual Sales: $7.39
Price / Book: 1.88

Profitability

EPS (TTM): -0.70000
Net Income (TTM): $-87.97M
Gross Margin: $244.6M
Return on Equity: -9.13%
Return on Assets: -5.17%

NeoGenomics Earnings Forecast

Key NeoGenomics Financial Ratios

  • The Gross Profit Margin over the past 24 years for NEO is 41.34%.
  • The Selling, General & Administrative Expenses for NEO have been equal to 53.06% of Gross Profit Margin.
  • The Research & Development expenses have been 4.62% of Revenue.
  • The Interest Expense is -7.85% of Operating Income.
  • The Net Earning history of NEO is -14.87% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 11 years.

NeoGenomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEO
CUSIP: 64049M
Website: neogenomics.com

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 6.2
Quick Ratio: 5.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 94.63

NEO Technical Analysis vs Fundamental Analysis

Sell
32
NeoGenomics (NEO) is a Sell

Is NeoGenomics a Buy or a Sell?

  • NeoGenomics stock is rated a Sell
    The current NeoGenomics [NEO] share price is $13.85. The Score for NEO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.